Apollomics closes $10 million private placement, insiders take part

Apollomics Inc. (Nasdaq: APLM) entered into definitive subscription agreements for a private placement with accredited investors for aggregate gross consideration of approximately $10.0 million.¹ The placement was expected to close on or about August 14, 2026, subject to customary closing conditions.¹

The deal involved two tranches. Cash subscriptions covered 533,334 Class A ordinary shares at $15.00 per share, generating gross cash proceeds of approximately $8.0 million before fees and expenses.¹ The second tranche was an automatic conversion of $2.0 million in principal from an unsecured convertible promissory note dated March 30, 2026, held by Chairman and CEO Hung-Wen (Howard) Chen, converting at $12.00 per share, or 80% of the cash investor price, into 166,667 Class A shares.¹

Company insiders participated alongside outside investors. Chen and/or his affiliates subscribed for an aggregate of 370,000 Class A shares, combining 103,333 cash subscription shares with the 166,667 shares from his note conversion.¹ Chief Financial Officer Peter Kuan-How Lin subscribed for 26,667 Class A shares for $400,005.00 in cash.¹ Maxpro Investment Co., Ltd., described as an affiliate of Chief Operating Officer and Director Yi-Kuei (Alex) Chen, subscribed for 20,000 Class A shares for $300,000.00.¹ Because Chen, Lin, and Maxpro took part, their subscriptions counted as related-party transactions under Nasdaq Rule 5630, and the filing said the independent Audit Committee reviewed and recommended the transactions before board approval, with Chen and Alex Chen abstaining on their own deals.¹

No placement agents or underwriters were used, and no finder's fees or commissions are payable.¹ Apollomics said it intends to use net cash proceeds for clinical development, working capital, and general corporate purposes.¹

A related Form D notice on the same offering listed a total offering amount of $10,000,000 with the total amount sold also at $10,000,000 and nothing remaining to be sold², and set the minimum investment accepted from any outside investor at $99,990.²